Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.97
Delayed Data
As of May 24
 +0.0699 / +7.77%
Today’s Change
0.46
Today|||52-Week Range
4.10
-19.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues20.1M29.9M27.1M18.2M
 
 
 
 
 
Depreciation And Amortization100.0K227.0K223.0K244.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses47.6M65.0M56.6M36.7M
 
 
 
 
 
Research And Development39.9M55.3M46.2M25.1M
 
 
 
 
 
Total Operating Expenses47.7M65.2M56.8M36.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.6M-35.3M-29.7M-18.8M
 
 
 
 
 
Extraordinary Credit6.3M3.2M4.0M1.9M
 
 
 
 
 
Extraordinary Charge0.000.00-531.0K0.00
 
 
Other Expenses-62.0K120.0K-19.0K-64.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.1M-31.8M-26.2M-16.8M
 
 
 
 
 
Net Income-21.1M-31.8M-26.2M-16.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.5M14.7M18.1M26.1M
 
 
 
 
 
Shares To Calculate EPS Diluted13.5M14.7M18.1M26.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.56-$2.17-$1.45-$0.64
 
 
 
 
 
EPS Diluted-$1.56-$2.17-$1.45-$0.64